#Blog

Access
All Articles




Radio Compass Blog

China approves vaccine candidate for military use; Big Pharma joins ‘Stop Hate for Profit’; discontinue Facebook ads

This week, Phispers brings you updates on vaccine development for Covid-19. While China’s military received the greenlight to use a Covid-19 vaccine candidate developed by CanSino Biologics, Tesla’s CEO Elon Musk said he is building mob...
2020-07-09

https://www.pharmacompass.com/radio-compass-blog/china-approves-vaccine-candidate-for-military-use-big-pharma-joins-stop-hate-for-profit-discontinue-facebook-ads

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 20497
Share Share info

#Blog

Access
All Articles




Radio Compass Blog

US buys up global stocks of Gilead’s remdesivir; India-China standoff leads to supply chain woes

This week, the Trump administration announced it would buyout global stocks of Gilead’s remdesivir for the next three months to fight Covid-19, while Gilead announced a tiered pricing for the antiviral drug in the US. A border-related dispute...
2020-07-02

https://www.pharmacompass.com/radio-compass-blog/us-buys-up-global-stocks-of-gilead-s-remdesivir-india-china-standoff-leads-to-supply-chain-woes

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 45226
Share Share info

#Blog

Access
All Articles




Radio Compass Blog

FDA issues Covid-19 guidelines for drug plants; Mylan scores win against Biogen’s MS drug patent

This week, Phispers brings you news on a GMP guidance document issued by the US Food and Drug Administration for responding to Covid-19 infection in employees in drug and biological products manufacturing. Biogen saw its key patent on its mult...
2020-06-25

https://www.pharmacompass.com/radio-compass-blog/fda-issues-covid-19-guidelines-for-drug-plants-mylan-scores-win-against-biogen-s-ms-drug-patent

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 71443
Share Share info

#Blog

Access
All Articles




Radio Compass Blog

Dexamethasone benefits severely ill Covid patients; FDA warning letter to Takeda’s sterile operations in Japan

This week, Phispers brings you more news on hydroxychloroquine (HCQ) as the US Food and Drug Administration withdrew its Emergency Use Authorization for Covid-19. The FDA also warned healthcare providers about a newly discovered potential drug intera...
2020-06-18

https://www.pharmacompass.com/radio-compass-blog/dexamethasone-benefits-severely-ill-covid-patients-fda-warning-letter-to-takeda-s-sterile-operations-in-japan

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 80776
Share Share info

#Blog

Access
All Articles




Radio Compass Blog

FDA defends its foreign inspections practices; WHO resumes HCQ Solidarity trials

This week, Phispers has more news on hydroxychloroquine (HCQ) as a treatment for Covid-19. While a large, randomized study in the UK termed it as “useless”, medical journal The Lancet retracted an influential study, which in turn, led t...
2020-06-11

https://www.pharmacompass.com/radio-compass-blog/fda-defends-its-foreign-inspections-practices-who-resumes-hcq-solidarity-trials

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 81972
Share Share info

#Blog

Access
All Articles




Radio Compass Blog

Sanofi overhauls executive committee; FDA recalls metformin due to unacceptable levels of NDMA impurity

This week, Phispers brings news on various developments across the world as a result of the Covid-19 pandemic. While US President Donald Trump ended America’s association with the WHO and thereby its US$ 400 million annual funding to the agen...
2020-06-04

https://www.pharmacompass.com/radio-compass-blog/sanofi-overhauls-executive-committee-fda-recalls-metformin-due-to-unacceptable-levels-of-ndma-impurity

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 87910
Share Share info

#Blog

Access
All Articles




Radio Compass Blog

WHO halts HCQ trials for Covid; Merck vs Merck: ‘Mercky’ saga continues; Akorn files for bankruptcy

This week, Phispers brings you updates on clinical trials for Covid-19 treatments and vaccines. While the WHO halted trials of HCQ for the novel coronavirus due to safety concerns, clinical data on remdesivir suggested that the drug is superior to ...
2020-05-28

https://www.pharmacompass.com/radio-compass-blog/who-halts-hcq-trials-for-covid-merck-vs-merck-mercky-saga-continues-akorn-files-for-bankruptcy

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 154745
Share Share info

#Blog

Access
All Articles




Radio Compass Blog

US rolls out Operation Warp Speed, announces US$ 354 million manufacturing contract for essential medicines

This week, Phispers brings you lots of updates on vaccine development, news and rhetoric emerging out of the ongoing Covid-19 pandemic. While Moderna posted positive results from the phase I clinical trial of its experimental vaccine, experts say t...
2020-05-21

https://www.pharmacompass.com/radio-compass-blog/us-rolls-out-operation-warp-speed-announces-us-354-million-manufacturing-contract-for-essential-medicines

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 150739
Share Share info

#Blog

Access
All Articles




Radio Compass Blog

Gilead signs deals for remdesivir production; Pfizer outsources drug-making to focus on Covid vaccine

This week, Phispers brings you news on how Covid-19 is pushing drugmakers to outsource manufacturing of drugs. While Gilead signed non-exclusive voluntary licensing agreements with five generic drugmakers based in India and Pakistan to increase the...
2020-05-14

https://www.pharmacompass.com/radio-compass-blog/gilead-signs-deals-for-remdesivir-production-pfizer-outsources-drug-making-to-focus-on-covid-vaccine

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 145242
Share Share info

#Blog

Access
All Articles




Radio Compass Blog

Trump admin wants to pull global supply chains out of China; FDA okays remdesivir for emergency use

This week, Phispers has news on remdesivir, Gilead’s investigational antiviral drug. The USFDA has issued an emergency use authorization for the drug for treatment of Covid-19. Gilead has said it plans to produce one million Remdesivir cour...
2020-05-07

https://www.pharmacompass.com/radio-compass-blog/trump-admin-wants-to-pull-global-supply-chains-out-of-china-fda-okays-remdesivir-for-emergency-use

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 66310
Share Share info
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty